Trial
NCT01851603
Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Colorado, Denver
Collaborators
National Institute of Mental Health (NIMH)
Condition
Schizophrenia
Intervention
AVL-3288
Why stopped
PI left institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-12-30